Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies
OwnerBernard Weill, Frederic Batteux +1inventors
InventorsBernard Weill, Frederic Batteux, Pierre-Jacques Ferret
Life of this patent
Estimating the term…
Abstract
The invention concerns the use of a compound having a superoxide dismustase activity, in particular a non-peptide analogue of the superoxide dismutase to obtain a medicine for preventive or curative treatment of hepatocellular insufficiency. Said medicine can be used in particular for treating hepatocellular insufficiencies of toxic or viral origin.
Claims14
The use of a manganese superoxide dismutase (MnSOD) mimetic for producing a medicament intended for the preventive or curative treatment of hepatocellular insufficiency.
The use of an MnSOD mimetic for protecting hepatic grafts during their preservation.
Dependencies are inferred from the claim text.